Package 55154-1426-8

Brand: invokana

Generic: canagliflozin
NDC Package

Package Facts

Identity

Package NDC 55154-1426-8
Digits Only 5515414268
Product NDC 55154-1426
Product ID 55154-1426_aad6a5e4-0449-44dd-8bb7-e9b17a1fbbc3
Description

720 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (55154-1426-8)

Marketing

Marketing Status
Marketed Since 2013-03-29
Brand invokana
Generic canagliflozin
Sample Package No

Linked Drug Pages (1)

INVOKANA ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "aad6a5e4-0449-44dd-8bb7-e9b17a1fbbc3", "openfda": {"upc": ["0355154142589", "0350458141306"], "unii": ["0SAC974Z85"], "rxcui": ["1373463", "1373469", "1373471", "1373473"], "spl_set_id": ["5f76e16f-0c24-454a-81af-4080b312c940"], "manufacturer_name": ["Cardinal Health 107, LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "720 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (55154-1426-8)", "package_ndc": "55154-1426-8", "marketing_start_date": "20130329"}], "brand_name": "INVOKANA", "product_id": "55154-1426_aad6a5e4-0449-44dd-8bb7-e9b17a1fbbc3", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["P-Glycoprotein Inhibitors [MoA]", "Sodium-Glucose Cotransporter 2 Inhibitor [EPC]", "Sodium-Glucose Transporter 2 Inhibitors [MoA]"], "product_ndc": "55154-1426", "generic_name": "canagliflozin", "labeler_name": "Cardinal Health 107, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "INVOKANA", "active_ingredients": [{"name": "CANAGLIFLOZIN", "strength": "300 mg/1"}], "application_number": "NDA204042", "marketing_category": "NDA", "marketing_start_date": "20130329", "listing_expiration_date": "20271231"}